U.S. Food And Drug Administration Approves Cayston(R) For The Improvement Of Respiratory Symptoms In Cystic Fibrosis PatientsGilead Sciences, Inc. (Nasdaq:GILD) announced that the U.S. Food and Drug Administration (
FDA) has granted marketing approval for Cayston(R)(aztreonam for inhalation solution) as a treatment to improve respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa (P. aeruginosa)...
Source: mnt.toFDA Approves First Generic Tamsulosin To Treat Enlarged Prostate GlandThe U.S. Food and Drug Administration approved the first generic version of Flomax Capsules 0.4 mg (tamsulosin hydrochloride) to treat benign prostatic hyperplasia (BPH), a condition in which an enlarged prostate gland causes problems with urination...
Source: mnt.toVion Pharmaceuticals Receives Response From FDA On Special Protocol Assessment For Onrigin(TM)VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VIONQ) announced that it had received a response from the U.S. Food and Drug Administration (
FDA) on a Special Protocol Assessment ("SPA") for its oncology therapeutic Onrigin™ (laromustine) Injection...
Source: mnt.toTesticular Cancer Diagnosis By Non-Invasive MRIResearchers have found that non-invasive magnetic resonance imaging (MRI) is a good diagnostic tool for the evaluation and staging of testicular cancer and may improve patient care by sparing some men unnecessary surgery, according to a study in the March issue of the American Journal of Roentgenology (http://www.ajronline.org)...
Source: mnt.toSperm Discovery Suggests New Target For Male ContraceptionMost of us probably think of sperm as rather active little cells, swimming with quick movements of their "tail" or flagella. But actually sperm's motility is in fact short lived. When in the male reproductive tract they have to rest easy, lest they wear themselves out prematurely and give up any chance of ever finding an egg...
Source: mnt.toInclement East Coast Weather Delays ProUroScan(TM) FDA ReviewProUroCare Medical, Inc. (OCT Bulletin Board: PUMD, PUMDU, PUMDW), a provider of proprietary medical imaging products, indicates that the Food and Drug Administration has informed the industry that the processing of 510(k) applications, which includes the ProUroScan™ prostate imaging system, has been delayed because of the inclement weather in February that impacted the Washington, D.C...
Source: mnt.toVaccine Approach Extends Life Of Metastatic Prostate Cancer PatientsIn a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, report researchers at Dana-Farber Cancer Institute and affiliated organizations...
Source: mnt.toOrthoDynamix LLC Receives FDA 510(k) Clearance For ArthroSteer(R) 3.5mm AblatorOrthoDynamix announced that it has received
FDA clearance for its new device, ArthroSteer 3.5mm Ablator, a mono polar electrosurgical device, for general surgical use, including the orthopedic and arthroscopic applications for resection, ablation, excision of soft tissue, hemostasis of blood vessels, and coagulating soft tissue in, but not limited to the knee, shoulder, and primarily the hip...
Source: mnt.to
# posted by Network @ 5:02 PM